These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 2390728)

  • 1. Dependence and withdrawal following intracerebroventricular and systemic morphine administration: functional anatomy and behavior.
    Adams RE; Wooten GF
    Brain Res; 1990 Jun; 518(1-2):6-10. PubMed ID: 2390728
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional cerebral glucose utilization in withdrawal following systemic and intracerebroventricular sufentanil administration.
    Adams RE; Wooten GF
    Neurochem Res; 1994 Oct; 19(10):1243-8. PubMed ID: 7891840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dose effects of naloxone on fixed morphine dependence: simultaneous behavioral and 2-deoxyglucose study in the rat.
    Geary WA; Wooten GF
    Brain Res; 1985 Apr; 332(1):69-78. PubMed ID: 4039615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is morphine dependence mediated exclusively by the Mu receptor?
    Adams RE; Wooten GF
    Neurochem Res; 1993 Oct; 18(10):1041-5. PubMed ID: 8255352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonidine attenuates increased brain glucose metabolism during naloxone-precipitated morphine withdrawal.
    Kimes AS; Bell JA; London ED
    Neuroscience; 1990; 34(3):633-44. PubMed ID: 2352645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the involvement of excitatory amino acid pathways in the development of precipitated withdrawal from acute and chronic morphine: an in vivo voltammetric study in the rat locus coeruleus.
    Hong M; Milne B; Jhamandas K
    Brain Res; 1993 Sep; 623(1):131-41. PubMed ID: 8221081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative involvement of supraspinal and spinal mu opioid receptors in morphine dependence in mice.
    Miyamoto Y; Takemori AE
    Life Sci; 1993; 52(12):1039-44. PubMed ID: 8383266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activation of oxytocin neurones by systemic cholecystokinin is unchanged by morphine dependence or withdrawal excitation in the rat.
    Brown CH; Munro G; Murphy NP; Leng G; Russell JA
    J Physiol; 1996 Nov; 496 ( Pt 3)(Pt 3):787-94. PubMed ID: 8930844
    [TBL] [Abstract][Full Text] [Related]  

  • 9. RP 67580, a selective antagonist of neurokinin-1 receptors, modifies some of the naloxone-precipitated morphine withdrawal signs in rats.
    Maldonado R; Girdlestone D; Roques BP
    Neurosci Lett; 1993 Jun; 156(1-2):135-40. PubMed ID: 7692360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interruption of central noradrenergic pathways and morphine withdrawal excitation of oxytocin neurones in the rat.
    Brown CH; Murphy NP; Munro G; Ludwig M; Bull PM; Leng G; Russell JA
    J Physiol; 1998 Mar; 507 ( Pt 3)(Pt 3):831-42. PubMed ID: 9508843
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential roles of corticotropin-releasing factor receptor subtypes 1 and 2 in opiate withdrawal and in relapse to opiate dependence.
    Lu L; Liu D; Ceng X; Ma L
    Eur J Neurosci; 2000 Dec; 12(12):4398-404. PubMed ID: 11122350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Time action profiles of regional cerebral glucose utilization during naloxone-precipitated morphine withdrawal.
    Geary WA; Wooten GF
    Brain Res; 1986 Dec; 399(1):181-4. PubMed ID: 3801919
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Height-dependent difference in the expression of naloxone-induced withdrawal jumping behavior in morphine dependent rats.
    Azizi H; Ranjbar-Slamloo Y; Semnanian S
    Neurosci Lett; 2012 May; 515(2):174-6. PubMed ID: 22465245
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regional cerebral glucose utilization during morphine withdrawal in the rat.
    Wooten GF; DiStefano P; Collins RC
    Proc Natl Acad Sci U S A; 1982 May; 79(10):3360-4. PubMed ID: 6954484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contribution of the region anterior and ventral to the third ventricle to opiate withdrawal excitation of oxytocin secretion.
    Russell JA; Pumford KM; Bicknell RJ
    Neuroendocrinology; 1992 Feb; 55(2):183-92. PubMed ID: 1620286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo tracer studies of glucose metabolism, cerebral blood flow, and protein synthesis in naloxone precipitated morphine withdrawal.
    Geary WA; Wooten GF
    Neurochem Res; 1987 Jul; 12(7):573-80. PubMed ID: 3614509
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence that 5-hydroxytryptamine in the forebrain is involved in naloxone-precipitated jumping in morphine-dependent rats.
    Cervo L; Romandini S; Samanin R
    Br J Pharmacol; 1983 Aug; 79(4):993-6. PubMed ID: 6686075
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of response-disruptive and somatic indices of opiate withdrawal during the initiation and development of opiate dependence.
    Schulteis G; Heyser CJ; Koob GF
    Behav Pharmacol; 1999 May; 10(3):235-42. PubMed ID: 10780239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analog of neuropeptide FF attenuates morphine abstinence syndrome.
    Malin DH; Lake JR; Leyva JE; Hammond MV; Rogillio RB; Arcangeli KR; Ludgate K; Moore GM; Payza K
    Peptides; 1991; 12(5):1011-4. PubMed ID: 1800944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sites of action of naloxone in precipitating withdrawal jumping in morphine-dependent mice: investigations by the ED50 value and CNS content of naloxone.
    Miyamoto Y; Takemori AE
    Drug Alcohol Depend; 1993 Apr; 32(2):163-7. PubMed ID: 8389690
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.